BELLINGER ANDREW (Chief Scientific Officer) exercised options at VERVE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/16/2022ACC: 0001209191-22-061697
Officer· Chief Scientific Officer
Since Jun 2021
0.00
Net shares
Net seller
$103.3K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
36K acquired · 36K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+36K
Price / share
$2.87
Trade value
$103.32K
% of position
543.1%
12/14/2022
6.63K→42.63K
Total
Net shares
+36K
Net value
$103.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/14/2022 | M · Option Exercise | +36K | $2.87 | $103.32K | 543.1% | 6.63K | 42.63K |
| Total | +36K | $103.32K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
36K shares
Shares
−36K
Strike price
2.87
Held after
179.99K
Exercisable
—
12/14/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock36K shares | 12/14/2022 | M · Option Exercise | −36K | 2.87 | — | 179.99K |